Insider · CIK 0001705564
William Enright
Files at BRNS (Barinthus Biotherapeutics plc.), BFRG (BullFrog AI Holdings, Inc.). First filing -, latest -.
In brief
William Enright files SEC Form 4 as CEO and director at BRNS (Barinthus Biotherapeutics plc.), and also at BFRG (BullFrog AI Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; William Enright has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Ordinary Sharesindirect: By Trust | -728,454 | - | - | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Ordinary Sharesindirect: By Trust | -514,923 | - | - | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -176,130 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -359,605 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -440,000 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -443,981 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -600,000 | $0.00 | $0 | 0 | 34 d ago |
| Jun 11, 2026 | BFRG BullFrog AI Holdings, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 15, 2026 |
| Sep 25, 2025 | BFRG BullFrog AI Holdings, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Sep 29, 2025 |
| Aug 22, 2025 | BFRG BullFrog AI Holdings, Inc. | AGrant or award Common Stock | +5,710 | $0.00 | $0 | 10,710 | Aug 26, 2025 |
| Aug 22, 2025 | BFRG BullFrog AI Holdings, Inc. | AGrant or award Common Stock | +2,813 | $0.00 | $0 | 13,523 | Aug 26, 2025 |
| Feb 3, 2025 | BRNS Barinthus Biotherapeutics plc. | AGrant or award Share Option (Right to Buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Feb 5, 2025 |
Questions about William Enright
Answered from the filings on this page, as of the latest one.
Is William Enright buying or selling?
William Enright has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did William Enright's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William Enright has 0.
Where does William Enright file Form 4?
William Enright has filed Form 4 at BRNS (Barinthus Biotherapeutics plc.) as Chief Executive Officer; BFRG (BullFrog AI Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.